Mark Noviski

787 total citations
14 papers, 302 citations indexed

About

Mark Noviski is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Mark Noviski has authored 14 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Mark Noviski's work include Chronic Lymphocytic Leukemia Research (6 papers), T-cell and B-cell Immunology (5 papers) and Nuclear Receptors and Signaling (4 papers). Mark Noviski is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), T-cell and B-cell Immunology (5 papers) and Nuclear Receptors and Signaling (4 papers). Mark Noviski collaborates with scholars based in United States and South Africa. Mark Noviski's co-authors include Julie Zikherman, James L. Mueller, Corey Tan, John Huizar, Lee Ann Garrett‐Sinha, Frank Brombacher, Anne B. Satterthwaite, Vivasvan S. Vykunta, Alexander Marson and Ryosuke Hiwa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature Immunology.

In The Last Decade

Mark Noviski

14 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Noviski United States	9	226	97	63	36	29	14	302
Rachel Soloff United States	11	211 0.9×	159 1.6×	66 1.0×	13 0.4×	16 0.6×	17	391
Maris Handley United States	6	184 0.8×	115 1.2×	74 1.2×	66 1.8×	37 1.3×	7	298
Dalal El‐Khoury United States	8	514 2.3×	126 1.3×	131 2.1×	8 0.2×	27 0.9×	11	607
G. Stuart Williams United States	9	253 1.1×	89 0.9×	15 0.2×	29 0.8×	68 2.3×	9	339
Charlotte G. Kæstel Denmark	8	186 0.8×	72 0.7×	54 0.9×	13 0.4×	27 0.9×	8	337
Paulina A García-González Chile	10	225 1.0×	71 0.7×	37 0.6×	6 0.2×	19 0.7×	14	312
Dorothea Reimer Germany	8	164 0.7×	79 0.8×	30 0.5×	6 0.2×	14 0.5×	9	249
James A. Kennedy Canada	5	160 0.7×	74 0.8×	122 1.9×	17 0.5×	13 0.4×	5	309
Anne Papaioannou Switzerland	5	159 0.7×	58 0.6×	61 1.0×	7 0.2×	46 1.6×	6	238
Gérald Hames Belgium	3	208 0.9×	164 1.7×	76 1.2×	38 1.1×	27 0.9×	3	287

Countries citing papers authored by Mark Noviski

Since Specialization

Citations

This map shows the geographic impact of Mark Noviski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Noviski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Noviski more than expected).

Fields of papers citing papers by Mark Noviski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Noviski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Noviski. The network helps show where Mark Noviski may publish in the future.

Co-authorship network of co-authors of Mark Noviski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Noviski. A scholar is included among the top collaborators of Mark Noviski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Noviski. Mark Noviski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ma, Jun, Michael P. Randall, Ming‐Chi Lu, et al.. (2024). BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models. Blood. 144(Supplement 1). 2988–2988. 1 indexed citations

Bravo, Brandon, Jun Ma, Joel McIntosh, et al.. (2023). Abstract 3423: NX-2127: A first-in-class clinical stage degrader of BTK and IKZF1/3 for the treatment of patients with B cell malignancies. Cancer Research. 83(7_Supplement). 3423–3423. 4 indexed citations

Noviski, Mark, Stephanie Yung, Jordan Ye, et al.. (2023). Abstract 2850: NX-5948 promotes selective, sub-nanomolar degradation of inhibitor-resistant BTK mutants. Cancer Research. 83(7_Supplement). 2850–2850. 2 indexed citations

Noviski, Mark, Jun Ma, Ernestine Lee, et al.. (2022). Abstract 1126: Concurrent degradation of BTK and IMiD neosubstrates by NX-2127 enhances multiple mechanisms of tumor killing. Cancer Research. 82(12_Supplement). 1126–1126. 6 indexed citations

Robbins, Daniel, Mark Noviski, Ryan B. Rountree, et al.. (2021). Nx-5948, a Selective Degrader of BTK with Activity in Preclinical Models of Hematologic and Brain Malignancies. Blood. 138(Supplement 1). 2251–2251. 35 indexed citations

Robbins, Daniel, Mark Noviski, Cristiana Guiducci, et al.. (2021). POS0006 NX-5948, A SELECTIVE DEGRADER OF BTK, SIGNIFICANTLY REDUCES INFLAMMATION IN A MODEL OF AUTOIMMUNE DISEASE. Annals of the Rheumatic Diseases. 80. 204–205. 5 indexed citations

Tan, Corey, Ryosuke Hiwa, James L. Mueller, et al.. (2020). NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting. Nature Immunology. 21(10). 1267–1279. 49 indexed citations

Tan, Corey, James L. Mueller, Mark Noviski, et al.. (2019). Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery. The Journal of Immunology. 202(10). 2907–2923. 22 indexed citations

Noviski, Mark, Corey Tan, John Huizar, et al.. (2019). Optimal Development of Mature B Cells Requires Recognition of Endogenous Antigens. The Journal of Immunology. 203(2). 418–428. 17 indexed citations

10.

Tan, Corey, Mark Noviski, John Huizar, & Julie Zikherman. (2019). Self‐reactivity on a spectrum: A sliding scale of peripheral B cell tolerance. Immunological Reviews. 292(1). 37–60. 34 indexed citations

11.

Noviski, Mark, James L. Mueller, Anne B. Satterthwaite, et al.. (2018). IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate. eLife. 7. 68 indexed citations

12.

Noviski, Mark & Julie Zikherman. (2018). Control of autoreactive B cells by IgM and IgD B cell receptors: maintaining a fine balance. Current Opinion in Immunology. 55. 67–74. 21 indexed citations

13.

Huizar, John, Corey Tan, Mark Noviski, James L. Mueller, & Julie Zikherman. (2017). Nur77 Is Upregulated in B-1a Cells by Chronic Self-Antigen Stimulation and Limits Generation of Natural IgM Plasma Cells. ImmunoHorizons. 1(9). 188–197. 15 indexed citations

14.

Noviski, Mark, et al.. (2015). An extracatalytic function of CD45 in B cells is mediated by CD22. Proceedings of the National Academy of Sciences. 112(47). E6515–24. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact